Dedalus UK is an ‘active supplier’ on the NHS Scotland HEPMA Framework

Following a rigorous evaluation, Dedalus UK is an accredited supplier on the Hospital Electronic Prescribing and Medicines Administration framework throughout Scotland

Dedalus, the largest European provider of healthcare information systems and #3 KLAS-rated for new clinical projects worldwide, was today named as an ‘Active Supplier’ on the NHS Scotland Hospital Electronic Prescribing and Medicines Administration (HEPMA) framework.  The framework, which is valued at £15m, covers 14 regional health boards and 2 national hospitals – the State Psychiatric Hospital and the Golden Jubilee Hospital (a national centre for heart and lung services and a major centre for orthopaedics).  With only 2 boards’ implemented to-date – one of which was implemented prior to the HEPMA framework establishment – there is still a huge opportunity for Dedalus to facilitate clinician-led e-prescribing and medicines administration that helps improve the quality of care and increase medicines safety across Scotland.

Following a very rigorous evaluation process covering a total of 1261 requirements, of which 462 were mandatory, Dedalus is pleased to have achieved 100% compliance on all NHS Scotland core functional specifications. Recognised by clinicians for its usability, and with a powerful interoperability capability, the Dedalus’ ePMA has been designed around clinical and ward-driven workflows across departments and organisations for quality care integration and ease of adoption.

Dedalus’ HEPMA solution supports the entire Board-wide electronic prescribing and medicines administration process.  It expedites the whole patient journey from pre-admission medicines history to discharge medications for inpatients, outpatients and day cases.  Designed from a clinical viewpoint, this powerful web-based clinical workflow solution gives the user an intuitive, easy to follow system that reflects daily practices and significantly eases adoption and encourages user engagement. The flexible underlying architecture can be aligned to support a wide variety of clinical roles and care locations, overcoming many of the disadvantages of the more rigid pharmacy stock management-based solutions.

The latest version of Dedalus’ ePMA solution, Planner for Care (P4C) embodies HTML5 and the latest FHIR (Fast Healthcare Interoperability Resources) standards, Dedalus supports Windows, iOS and Android operating systems and can therefore be used on a wide variety of workstations, tablets or mobile devices for use by clinicians at the bedside, on the drugs trolley, in the pharmacy or outpatient clinics.  The solution comes with the NHS dm+d (dictionary of medicines and devices) catalogue as native.  This, now mandatory, standard ensures the safe and reliable transfer of medicines information between clinical systems and cross-care settings.  This, together with the in-built Snomed-CT clinical coding, ensures the clarity of all patient ailments and treatments throughout the care continuum.

“We are delighted to have been awarded this accreditation across Scotland,” said Judy Smith, Managing Director at Dedalus Healthcare Ltd. “Our acceptance as ‘Active Supplier’ ensures that we can bring the powerful, user-friendly capabilities of HEPMA to Scottish clinicians and we look forward to bidding on all upcoming mini-tenders.  Our exceptional 4HealthSolutions interoperability platform, which underpins the Dedalus portfolio, also ensures any existing hospital systems can be smoothly integrated to provide a complete care record essential in meeting Scotland’s Digital Health and Care Strategy.”

Implementing a hospital-wide system demands huge changes in working practices and systems knowledge.  At Dedalus, our Transformation team offers proven methodologies to ensure Trusts take into account all stakeholder needs, while harnessing the full potential of the workforce and any existing systems, to jointly deliver a solution that meets the operational needs of clinicians and improves patient care.


Chris Heys joins Dedalus UK – a company with an exceptional diagnostics portfolio and work ethic!

With over 12 years as a Biomedical Scientist (BMS) and numerous years in sales of diagnostic systems with companies such as Agfa and Menarini, Chris Heys joins the Dedalus UK team.  With in-depth knowledge of the needs of NHS Pathology from the clinical side and a successful sales career, Chris joins as UK Diagnostic Sales to help expand the Dedalus UK footprint.

As the largest European provider of healthcare information systems, with implementations on 4 continents, in 25 countries and a multi-million Euro R&D budget, Chris joins a dynamic growing company with substantial UK expansion plans.

“It was the commitment and dynamism of the UK team that drove me to join,” states Chris.   “Dedalus is certainly a company going places and their product portfolio is very powerful with an exciting vision.  It is brilliant to be joining a company with such an exceptional offering and great work ethic.”

A specialist in interoperability and clinical workflow solutions, Dedalus is one of the only solutions to support the entire Anatomical Pathology process from specimen registration and tracking, to remote diagnosis and collaborative reporting. With its powerful interoperability platform, Dedalus allows connectivity across all laboratory disciplines, all laboratory equipment, out to satellite labs and remote Trusts to provide a fully integrated Pathology solution.

#3 KLAS-rated for new clinical projects worldwide, Dedalus has over 1,500 client hospitals worldwide and covers the full spectrum of healthcare solutions from Digital Pathology, LIMS Interoperability, Laboratory Automation, Digital Storage, Asset Tracking, Population Health Management, e-Prescribing, Interoperability, Business Intelligence, ERP and Billing solutions. With headquarters in Florence Italy, the Dedalus Group has operations in China, Japan, South Africa, Middle East, USA, Latin America, France and the UK.

 

Follow us on – https://www.linkedin.com/company/dedalus-healthcare-limited/

& on Twitter – https://twitter.com/DedalusUK

For more information:  http://www.dedalus-uk.com/diagnostic-information-system.html


Peter Gilfoyle joins Dedalus UK and adds NHS clinical insight to Digital Pathology portfolio

With a 30 year pedigree in Cellular Pathology, in organisations such as Leeds General Infirmary, and over 10 years successful IT solutions expertise, Peter Gilfoyle joins the growing Dedalus UK team as Diagnostic Care Solution Specialist. With 8-10 Go-live lab implementations, Peter brings not only a wealth of clinical knowledge but also a vast front-line experience in bringing expectations into operational reality.

“As clinical workflow specialists, Dedalus has a wealth of expertise throughout Europe,” states Peter.  “Their product solution set is exceptional.  Part of my role is to ensure this portfolio meets the needs of UK clinicians both operationally and in any future developments.  The Smart Imaging solution, for example, is particularly stunning and will shorten collaborative diagnoses times dramatically allowing Trusts to meet e.g. 2-week wait targets.”

Dedalus is one of the only solutions to support the entire Anatomical Pathology process from specimen registration and tracking, to remote diagnosis and collaborative reporting. With its powerful interoperability platform, Dedalus allows connectivity across all laboratory disciplines, all laboratory equipment, out to satellite labs and remote Trusts to provide a fully integrated Pathology solution.

#3 KLAS-rated for new clinical projects worldwide, Dedalus has over 1,500 client hospitals worldwide and covers the full spectrum of healthcare solutions from Digital Pathology, LIMS Interoperability, Laboratory Automation, Digital Storage, Asset Tracking, Population Health Management, e-Prescribing, Interoperability, Business Intelligence, ERP and Billing solutions. With headquarters in Florence Italy, the Dedalus Group has operations in China, Japan, South Africa, Middle East, USA, Latin America, France and the UK.

 

Follow us on – https://www.linkedin.com/company/dedalus-healthcare-limited/

& on Twitter – https://twitter.com/DedalusUK @dedalusuk

 

For more information:  http://www.dedalus-uk.com/diagnostic-information-system.html


Dedalus UK awarded G-Cloud 10 Supplier status

As of 2nd July 2018, NHS Trusts are now able to purchase Electronic Prescribing and Digital Pathology solutions from Dedalus as SaaS (Software-as-a-Service).  This Cloud offering will not only negate the need for a full tender process but it will also simplify and shorten procurement timescales and reduce the overall cost of ownership.  For those hospitals wishing to stay inside tight budgets and buy via the online ‘Digital Marketplace’ Dedalus UK also has some invaluable proof-points that can help prepare the business cases.

This SaaS offering provides end users with a scalable solution and automatic updates of the software all for a monthly fee with little or no upfront hardware or license costs.  With security a major issue in healthcare organisations, with numerous security breaches making the UK news, the Cloud ensures the very latest data and internet security standards are in play.

With a recent UK report showing 1/3rd of NHS Trusts are already delivering part of their infrastructure through the Cloud and a further 39% are planning to do so within the next two years – this is a very timely announcement for Dedalus.